Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breath from Salt: A Story of Tenacity.

Anesthesiology·2025
Same author

Centromere defects, chromosome instability, and cGAS-STING activation in systemic sclerosis.

Nature communications·2022
Same author

Intraoperative Anaphylaxis to the Bovine Flowable Gelatin Matrix: A Report of 2 Cases.

JBJS case connector·2022
Same author

Utility of a Telephone Triage Hotline in Response to the COVID-19 Pandemic: Longitudinal Observational Study.

Journal of medical Internet research·2021
Same author

Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study.

BMJ open·2020
Same author

The role of the histone H3 variant CENPA in prostate cancer.

The Journal of biological chemistry·2020

Related Experiment Video

Updated: Jan 10, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K

Genetic Testing for Malignant Hyperthermia Susceptibility-Threading the Needle in the Haystack.

Anjan K Saha1, Teeda Pinyavat1

  • 1Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY 10032, USA.

Genes
|November 27, 2025
PubMed
Summary

Malignant hyperthermia (MH) is a rare genetic disorder. Advances in genetic testing offer improved diagnostics and risk assessment for MH susceptibility, extending beyond anesthesia care.

Keywords:
genetic testingmalignant hyperthermianext-generation sequencingpatient safetyperioperative medicine

More Related Videos

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

1.9K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.8K

Related Experiment Videos

Last Updated: Jan 10, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

1.9K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.8K

Area of Science:

  • Anesthesiology
  • Pharmacogenetics
  • Molecular Diagnostics

Background:

  • Malignant hyperthermia (MH) is a rare, life-threatening pharmacogenetic disorder.
  • Traditionally diagnosed via caffeine-halothane contracture testing, its prevalence is linked to specific gene variants (RYR1, CACNA1S, STAC3).
  • Next-generation sequencing (NGS) has revolutionized MH diagnostics, enabling enhanced perioperative risk assessment.

Purpose of the Study:

  • To review historical advancements, current understanding, and future directions in Malignant hyperthermia (MH) diagnostics.
  • To guide clinicians in utilizing molecular diagnostics for personalized patient care and safety.
  • To explore the broader implications of MH susceptibility beyond the operating room.

Main Methods:

  • Literature review synthesizing historical data, current consensus, and emerging research on Malignant hyperthermia (MH).
  • Analysis of the impact of next-generation sequencing (NGS) on MH diagnostics.
  • Discussion of challenges in genetic testing, including variant interpretation and functional assays.

Main Results:

  • NGS offers improved diagnostic capabilities for Malignant hyperthermia (MH), complementing or replacing traditional testing.
  • Genetic testing for MH susceptibility presents challenges such as incomplete penetrance and variant pathogenicity.
  • Emerging evidence links MH susceptibility genes to exertional heat illness and rhabdomyolysis.

Conclusions:

  • Molecular diagnostics are transforming Malignant hyperthermia (MH) management, enabling personalized perioperative care.
  • A broader framework is needed to assess genetic risks associated with MH susceptibility, including non-anesthetic implications.
  • Continued research is crucial for refining diagnostic accuracy and understanding the full spectrum of MH-related conditions.